D2C Skincare Brand Be Clinical Raises ₹21 Crore for Portfolio Expansion

D2C skincare brand Be Clinical has raised ₹21 crore (approximately $2.2 million) in a seed extension funding round. The round was led by Sauce, with participation from existing investor V3 Ventures.

The newly acquired capital will be allocated to strengthening research and development capabilities, expanding its skin, body, and haircare product portfolio, scaling manufacturing capacity, and entering new markets. The company also plans to enhance its team and invest further in clinical testing and production facilities.

Founded in 2025 after two years of R&D, Be Clinical develops clinically tested products containing dermatologically active ingredients aimed at addressing age-related concerns for consumers. The brand emphasizes its commitment to rigorous clinical testing and in-house manufacturing to ensure product quality and efficacy.

Be Clinical competes within India's crowded beauty and personal care market against both domestic and international brands. This funding round comes amid growing consumer demand for skincare products that feature active ingredients and are backed by clinical validation.